012423AA7
Albany Molecular Research, Inc.
Could not find a ticker for this position, may be a filing error
A contract research, development, and manufacturing organization that helps pharmaceutical companies create and produce medicines, best known for developing the active ingredient in the allergy drug Allegra. Founded in 1991 in Albany, New York, by two former Sterling Winthrop scientists who started with custom synthesis work in lab space lent by Siena College. The company rebranded as Curia in 2021, taking a Latin name meaning "purposeful assembly" to reflect its global reach beyond its Albany roots.
CONVERTIBLEUnderlying: AMRICUSIP: 012423AA7HealthcareUS1 derivative reporter
Convertible Senior Unsecured Notes 144A
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
